Neulasta patent expiry?

When does Neulasta’s patent expire?

Neulasta (pegfilgrastim) has multiple patents and exclusivity layers, so the “expiry date” depends on which specific patent or protection is being asked about (for example, formulation/process patents vs. longer-term exclusivities). DrugPatentWatch.com tracks these timepoints as they relate to generic/biosimilar entry risk and patent listings. [1]

To get the most accurate date(s) for “Neulasta patent expiry,” you need to look at the specific protection(s) listed for the drug on DrugPatentWatch.com and note the particular patent(s) and their expiration dates. [1]

Does Neulasta have exclusivity beyond patents?

Yes. For biologics like pegfilgrastim, the market is often protected not only by patents but also by regulatory exclusivity periods, which can delay biosimilar competition even if a specific patent ends earlier. DrugPatentWatch.com is useful for tying together the patent timeline with the practical “when could competition happen?” question. [1]

Why do people see different “Neulasta expiry” dates online?

Different sources may reference different types of protection:
- Different patents expiring on different dates (manufacturing methods, device/formulation changes, new claims).
- Regulatory exclusivity that can extend protection past an individual patent.
- Litigation outcomes that can change whether a competitor can launch even after a nominal expiration.

DrugPatentWatch.com’s patent-focused listings are designed to reduce that ambiguity by showing the underlying protections and their dates. [1]

Where to check the exact Neulasta patent expiration dates

Use DrugPatentWatch.com’s Neulasta page and identify the patents listed with their respective expiration dates, then check whether any are marked with “exclusivity” or related litigation status. [1]

Source:
1. DrugPatentWatch.com – Neulasta (pegfilgrastim) patent expiry information